Aquestive Therapeutics, Inc. (AQST): Insider Trades and Fund Holdings
In the past 12 months, Aquestive Therapeutics, Inc. insiders reported 0 open-market purchases worth $0 and 4 sales worth $379K; 4 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144) and fund moves in the past year, newest first.
- Oct 15, 2026Insider saleCEO Daniel Barber sold $105,600 under a 10b5-1 plan (1 days after: signed a material agreement)
- Oct 14, 2026NewsCompany reported: Signed a material agreement
- Sep 29, 2026NewsCompany reported: Executive or director change
- Sep 15, 2026Insider saleCEO Daniel Barber sold $120,487 under a 10b5-1 plan
- Sep 15, 2026Planned saleDaniel Barber (director, officer) filed notice to sell about $244,000 around Sep 15, 2026
- Sep 9, 2026Insider saleChief Commercial Officer Sherry Korczynski sold $45,675 under a 10b5-1 plan
- Sep 9, 2026Planned saleSherry M. Korczynski (officer) filed notice to sell about $45,588 around Sep 9, 2026
- Aug 17, 2026Insider saleCEO Daniel Barber sold $107,168 under a 10b5-1 plan
- Aug 17, 2026Planned saleDaniel Barber (officer) filed notice to sell about $106,250 around Aug 17, 2026
- Jun 30, 2026FundRenaissance Technologies opened a position in Q2 2026 (13F filed Aug 13, 2026)
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 16, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 16 | Daniel BarberCEO | ▼ SELL10b5-1 | $106K |
| Sep 16 | Daniel BarberCEO | ▼ SELL10b5-1 | $120K |
| Sep 11 | Sherry KorczynskiChief Commercial Officer | ▼ SELL10b5-1 | $46K |
| Aug 18 | Daniel BarberCEO | ▼ SELL10b5-1 | $107K |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Daniel Barber | CEO | 0 | $0 | 3 | $333K |
| Sherry Korczynski | Chief Commercial Officer | 0 | $0 | 1 | $46K |
Buybacks and executive pay
| Year | CEO pay reported | CEO pay "actually paid" | Value of $100 invested |
|---|---|---|---|
| 2025 | $3.49M | $11.0M | n/a |
| 2024 | $4.18M | $5.23M | n/a |
| 2023 | $2.50M | $3.28M | n/a |
From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.
Tracked funds that report AQST
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 416,248 | $1.73M | ▲ New |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →